Hans-Christian Mochmann1, Jan F Scheitz1, Gabor C Petzold1, Karl Georg Haeusler1, Heinrich J Audebert1, Ulrich Laufs1, Christine Schneider1, Ulf Landmesser1, Nikos Werner1, Matthias Endres1, Bernhard Witzenbichler1, Christian H Nolte2. 1. From Klinik für Kardiologie (H.-C.M., U.L.) and Klinik für Neurologie (J.F.S., K.G.H., H.J.A., M.E., C.H.N.), Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany; Center for Stroke Research Berlin (J.F.S., K.G.H., H.J.A., M.E., C.H.N.) and ExcellenceCluster NeuroCure (M.E.), Charité-Universitätsmedizin Berlin, Germany; German Center for Neurodegenerative Diseases and Department of Neurology(G.C.P., C.S.) and Department of Internal Medicine II (N.W.), University of Bonn, Germany; Klinik für Innere Medizin III, Kardiologie, Angiologie undInternistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany (U.L.); German Center for Neurodegenerative Diseases, Berlin,Germany (M.E.); Berlin Institute of Health, Germany (M.E.); and Klinik für Kardiologie und Pneumologie, Helios Amper-Klinikum Dachau, Germany (B.W.). 2. From Klinik für Kardiologie (H.-C.M., U.L.) and Klinik für Neurologie (J.F.S., K.G.H., H.J.A., M.E., C.H.N.), Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany; Center for Stroke Research Berlin (J.F.S., K.G.H., H.J.A., M.E., C.H.N.) and ExcellenceCluster NeuroCure (M.E.), Charité-Universitätsmedizin Berlin, Germany; German Center for Neurodegenerative Diseases and Department of Neurology(G.C.P., C.S.) and Department of Internal Medicine II (N.W.), University of Bonn, Germany; Klinik für Innere Medizin III, Kardiologie, Angiologie undInternistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany (U.L.); German Center for Neurodegenerative Diseases, Berlin,Germany (M.E.); Berlin Institute of Health, Germany (M.E.); and Klinik für Kardiologie und Pneumologie, Helios Amper-Klinikum Dachau, Germany (B.W.). christian.nolte@charite.de.
Abstract
BACKGROUND: A relevant proportion of patients with acute ischemic stroke (AIS) have elevated levels of cardiac troponins (cTn). However, the frequency of coronary ischemia as the cause of elevated cTn is unknown. The aim of our study was to analyze coronary vessel status in AIS patients with elevated cTn compared with patients presenting with non-ST-segment-elevation acute coronary syndrome (NSTE-ACS). METHODS AND RESULTS: Among 2123 consecutive patients with AIS prospectively screened at 2 tertiary hospitals, 13.7% had cTn elevation (>50 ng/L). According to a prespecified sample size estimation, 29 patients with AIS (median age, 76 years [first-third quartiles, 70-82 years]; 52% male) underwent conventional coronary angiography and were compared with age- and sex-matched patients with NSTE-ACS. The primary end point was presence of coronary culprit lesions on coronary angiograms as analyzed by independent interventional cardiologists blinded for clinical data. Median cTn on presentation did not differ between patients with AIS or NSTE-ACS (95 versus 94 ng/L; P=0.70). Compared with patients with NSTE-ACS, patients with AIS were less likely to have coronary culprit lesions (7 of 29 versus 23 of 29; P<0.001) or any obstructive coronary artery disease (15 of 29 versus 25 of 29; P=0.02; median number of vessels with >50% stenosis, 1 [first-third quartiles, 0-2] versus 2 [first-third quartiles, 1-3]; P<0.01). CONCLUSIONS: Coronary culprit lesions are significantly less frequent in AIS patients compared with age- and sex-matched patients with NSTE-ACS despite similar baseline cTn levels. Half of all AIS patients had no angiographic evidence of coronary artery disease. Further studies are needed to clinically identify the minority of patients with AIS and angiographic evidence of a culprit lesion. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01263964.
BACKGROUND: A relevant proportion of patients with acute ischemic stroke (AIS) have elevated levels of cardiac troponins (cTn). However, the frequency of coronary ischemia as the cause of elevated cTn is unknown. The aim of our study was to analyze coronary vessel status in AIS patients with elevated cTn compared with patients presenting with non-ST-segment-elevation acute coronary syndrome (NSTE-ACS). METHODS AND RESULTS: Among 2123 consecutive patients with AIS prospectively screened at 2 tertiary hospitals, 13.7% had cTn elevation (>50 ng/L). According to a prespecified sample size estimation, 29 patients with AIS (median age, 76 years [first-third quartiles, 70-82 years]; 52% male) underwent conventional coronary angiography and were compared with age- and sex-matched patients with NSTE-ACS. The primary end point was presence of coronary culprit lesions on coronary angiograms as analyzed by independent interventional cardiologists blinded for clinical data. Median cTn on presentation did not differ between patients with AIS or NSTE-ACS (95 versus 94 ng/L; P=0.70). Compared with patients with NSTE-ACS, patients with AIS were less likely to have coronary culprit lesions (7 of 29 versus 23 of 29; P<0.001) or any obstructive coronary artery disease (15 of 29 versus 25 of 29; P=0.02; median number of vessels with >50% stenosis, 1 [first-third quartiles, 0-2] versus 2 [first-third quartiles, 1-3]; P<0.01). CONCLUSIONS: Coronary culprit lesions are significantly less frequent in AIS patients compared with age- and sex-matched patients with NSTE-ACS despite similar baseline cTn levels. Half of all AIS patients had no angiographic evidence of coronary artery disease. Further studies are needed to clinically identify the minority of patients with AIS and angiographic evidence of a culprit lesion. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01263964.
Authors: Michael R Jones; George Howard; Gary S Roubin; Joseph L Blackshear; David J Cohen; Donald E Cutlip; Pierre P Leimgruber; David Rhodes; Ronald J Prineas; Stephen P Glasser; Brajesh K Lal; Jenifer H Voeks; Thomas G Brott Journal: Circ Cardiovasc Qual Outcomes Date: 2018-11
Authors: Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg Journal: Nat Rev Cardiol Date: 2017-04-06 Impact factor: 32.419
Authors: Peter Wrigley; Jane Khoury; Bryan Eckerle; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Mathew L Flaherty; Felipe De Los Rios la Rosa; Jason Mackey; Opeolu Adeoye; Sharyl Martini; Simona Ferioli; Brett M Kissela; Dawn O Kleindorfer Journal: Stroke Date: 2017-04-05 Impact factor: 7.914
Authors: M Kruska; C Fastner; J F Scheitz; A Kolb; M Rutsch; T Papavassiliu; M Borggrefe; A Alonso; I Akin; K Szabo; S Baumann Journal: Herz Date: 2020-07-06 Impact factor: 1.443
Authors: Eva Latorre; Luke C Pilling; Benjamin P Lee; Stefania Bandinelli; David Melzer; Luigi Ferrucci; Lorna W Harries Journal: Clin Sci (Lond) Date: 2018-02-02 Impact factor: 6.124